Csenge Advisory Group Has $473,000 Stake in Synopsys, Inc. (NASDAQ:SNPS)

Csenge Advisory Group lowered its stake in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 975 shares of the semiconductor company’s stock after selling 40 shares during the period. Csenge Advisory Group’s holdings in Synopsys were worth $473,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Kieckhefer Group LLC bought a new stake in Synopsys during the fourth quarter worth approximately $27,000. Hazlett Burt & Watson Inc. lifted its stake in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after buying an additional 20 shares during the last quarter. Princeton Global Asset Management LLC bought a new stake in shares of Synopsys during the 3rd quarter worth $44,000. nVerses Capital LLC acquired a new position in Synopsys in the 3rd quarter valued at $51,000. Finally, Newbridge Financial Services Group Inc. bought a new position in Synopsys in the 4th quarter worth $51,000. Institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Synopsys stock opened at $525.00 on Wednesday. The business has a 50 day simple moving average of $511.06 and a 200 day simple moving average of $517.59. Synopsys, Inc. has a one year low of $457.52 and a one year high of $629.38. The company has a market capitalization of $81.15 billion, a PE ratio of 36.16, a price-to-earnings-growth ratio of 3.49 and a beta of 1.12.

Wall Street Analyst Weigh In

SNPS has been the subject of a number of recent analyst reports. Rosenblatt Securities restated a “buy” rating and set a $635.00 price target on shares of Synopsys in a report on Wednesday, December 4th. Piper Sandler lowered their target price on Synopsys from $670.00 to $655.00 and set an “overweight” rating on the stock in a report on Friday, December 6th. Wells Fargo & Company cut their price target on Synopsys from $570.00 to $540.00 and set an “equal weight” rating for the company in a report on Monday, January 13th. Loop Capital started coverage on shares of Synopsys in a research note on Monday, November 11th. They issued a “buy” rating and a $675.00 price objective on the stock. Finally, Redburn Atlantic began coverage on shares of Synopsys in a report on Monday, January 13th. They set a “buy” rating and a $600.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $641.82.

Insider Buying and Selling at Synopsys

In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.66% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.